Berdazimer Gel 10.3% (Zelsuvmi) for Molluscum Contagiosum

Berdazimer Gel 10.3% (Zelsuvmi) for Molluscum Contagiosum

The FDA approved Berdazimer Gel 10.3% (Zelsuvmi) for Molluscum Contagiosum on 5th January 2024. Berdazimer Gel 10.3% (Zelsuvmi) is the second topical medicine approved so far for the treatment of Molluscum Contagiosum (MC). The first one, cantharidin, was approved in 2023. Curettage is more effective than Cantharidin. However, it has not been compared with Berdazimer … Read more

Weight Regain after Stopping Ozempic: What to do?

ozempic weight regain

Ozempic (Semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood sugar levels and reduce appetite, leading to weight loss. However, once you stop taking the medication, your appetite and blood sugar levels may return to pre-treatment levels, which could cause weight gain. It’s important to remember that weight loss and weight management … Read more

Entyvio vs Humira (Vedolizumab Vs Adalimumab)

entyvio vs humira vedolizumab vs adalimumab

Entyvio vs Humira (Vedolizumab Vs Adalimumab) is a head to head comparison of the two tumor necrosis factor inhibitors (TNF inhibitors) in the treatment of patients with inflammatory bowel diseases. Entyvio is a humanized IgG1 monoclonal antibody that acts against α4β7 integrin which plays a main role in gastrointestinal inflammation. While Humira is a TNF … Read more

Entyvio vs Remicade (Vedolizumab vs Infliximab) – IBD

entyvio vs remicade vedolizumab vs infliximab

Entyvio vs Remicade compares the two drugs that target the tumor necrosis factor pathway. Entyvio is the brand name of Vedolizumab and is indicated primarily for the treatment of Crohn’s disease and ulcerative colitis. Remicade is infliximab indicated for autoimmune rheumatic conditions. Remicade is a chimeric monoclonal IgG1 antibody that inhibits TNF-α, which is the … Read more

Orencia vs Enbrel (Abatacept Vs Etanercept) – Comparison

orencia vs enbrel abatacept vs etanercept

Orencia vs Enbrel is a comparison of the two TNF inhibitors, Abatacept and Etanercept. Both drugs are being used to treat autoimmune rheumatic conditions, primarily Rheumatoid arthritis. Orencia and Enbrel both are indicated in chronic inflammatory conditions. Orencia (Abatacept) is a disease-modifying antirheumatic drug (DMARDs) use for the treatment of rheumatoid arthritis and active juvenile … Read more

Skyrizi vs Tremfya (Risankizumab Vs Guselkumab) – Comparison

Skyrizi vs Tremfya (Risankizumab Vs Guselkumab) is a comparison of the two monoclonal antibodies which selectively target and block Interleukin-23. IL-23 is an inflammatory cytokine that activates CD4 + T-helper (Th17) cell pathway to activate the inflammation cascade that is responsible for psoriatic plaque formation.  Both of these drugs are indicated in the treatment of … Read more

Simponi Vs Cimzia (Golimumab Vs Certolizumab) – Comparisons

simponi vs cimzia golimumab vs certolizumab uses differences

Simponi vs Cimzia is a comparison of the two novel TNF-inhibitors. Both the drugs can be administered as slow intravenous infusions or subcutaneous injections. This article explains the comparative pharmacokinetics, mechanism of action, and efficacies of two TNF inhibitors Simponi (golimumab) and Cimzia (certolizumab) in various conditions. Both of these drugs are indicated in chronic … Read more

Simponi vs Remicade (Golimumab Vs Infliximab)

simponi vs remicade golimumab vs infliximab

Simponi vs Remicade is a comparison between two drugs Simponi (Golimumab) and Remicade (Infliximab). Both of them are TNF (Tumor Necrosis Factor) Inhibitors. These drugs aid in the treatment of chronic inflammation in various conditions. This comparison is based on the mechanism of action, pharmacokinetics, and efficacy in different conditions. Indications and Uses: Simponi vs … Read more

Rituximab Vs Infliximab (Rituxan Vs Remicade) – Comparison

rituximab vs infliximab rituxan vs remicade

Rituximab Vs Infliximab is a comparison of the two drugs. Rituximab is a monoclonal antibody that targets CD-20 Positive B Lymphocytes While Infliximab is a TNF Inhibitor. Drug Description: Rituximab Vs Infliximab: Rituximab Infliximab Class Monoclonal type I CD20 antibody Tumor necrosis factor (TNF-alpha or TNF-α) blocker Chimeric Monoclonal IgG1 antibody Trade Names MabThera, Rixathon, … Read more